Calls for Tender and Programmes for Start-up Businesses

Calls for Tender and Programmes for Start-up Businesses

Non-refundable grants and programmes for start-up businesses

Here follows an overview of all credit facilities under the programme Smart&Start 2020, designed exclusively for innovative start-ups based across Italy, which allow businesses to receive funds from 100,000 to 1.5 million euros. The business idea shall have technological and innovative characteristics, such as focusing on product development, services, solutions in the domain of digital economy or enhancing the outcomes of the research system from an economic viewpoint.

The credit facilities consist of a no-interest loan to be paid back in a 10-year period to cover the investment and management costs resulting from the launch of the project.

Start-up businesses based in the Italian regions of Abruzzo, Basilicata, Campania, Molise, Apulia, Sardinia and Sicily, have been offered a refundable grant covering 30% of the loan.

Smart&Start Italy shall provide start-ups established less than a year ago with a series of technical and managerial support services.

There are neither deadlines nor ranking order. Invitalia will evaluate the applications based on the order of receipt until funds are used up.

View the Call for Tender.

Calls for Assisted Finance

Assisted finance includes all those measures that national and local lawmakers implement with the objective of providing businesses with more beneficial financial tools than those available on the market to promote new projects, make new investments or hire new staff.

The project called ‘Resto al Sud’ (I stay in the South) has been set up to encourage new businesses in the southern part of Italy. The Finance Law for the year 2020 has also included people under the age of 46 and freelance professionals. Beneficiaries are young people aged 18 to 45 years living in the Abruzzo, Basilicata, Campania, Molise, Apulia, Sardinia and Sicily regions at the date the application was submitted. Invitalia is managing the incentives and about 40% of the applications have been granted so far.

Financial incentives allow those eligible according to the requirements to receive up to 50 thousand euros for single individuals and up to 200 thousand euros for businesses of four or more partners. In addition, please note that the funding opportunities are aimed at covering 100% of allowed expenses.

Which sectors are covered?

  • Goods production in the following sectors: industry, craftsmanship, and processing of agricultural, fishing and aquaculture products;
  • Services for businesses and people;

The Call does not have a deadline, but applications are examined and granted based on their submission order.

Applications shall be filed through the online platform accessible from the website



Start-up Meet Pharma

It is an acceleration programme funded by the EIT Health network that brings together the main start-ups and pharmaceutical partners across Europe.

The programme has been outlined to meet some ‘challenges’ launched by pharmaceutical companies and the start-ups have the opportunity to present their solutions.


Deadline for applications: 30 March 2020.

Objectives: Developing innovative solutions for the pharmaceutical sector.

According to the programme, start-ups will work in cooperation with the pharmaceutical companies that launched the ‘challenges’ and they will also follow four training modules.

Start-ups shall be selected based on the good quality of their business idea, their eligibility to one of the ‘challenges’, motivation and degree of involvement of their team.

The programme is aimed at start-ups that manufacture products or prototypes which are already on the market or are about to enter it.

These are the ‘challenges’ launched this year:

  • Type of disease: cardiology;
  • Type of disease: multiple myeloma;
  • Type of disease: cardiology, oncology, gynaecology, ophthalmology, haematology and women’s health;
  • Type of disease: diabetes, skin diseases;
  • Type of disease: interstitial lung diseases.